Prostate Cancer Aggressiveness May Be Assessed by Probing the Metabolome

Prostate cancer may be indolent, justifying a “wait and see” approach, or it may be aggressive, warranting decisive action up to and including prostatectomy. The problem is, it can be hard to tell which, even after PSA (prostate-specific antigen) screening and histological analysis of biopsy tissue. Among the men who are diagnosed with prostate cancer, more than 70% are likely to have less aggressive tumors that follow an indolent course, and about 17% have aggressive, potentially fa